Zeifman R
NYU Center for Psychedelic Medicine, NYU Grossman School of Medicine, New York, NY 10016, USA.
PreprintPsilocybin
Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”
PreprintPsychedelics
On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy
PreprintPsilocybin
Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”
PreprintPsilocybin
Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial
PreprintPsilocybin
Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion
PreprintPsilocybin
Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder
ArticlePsilocybin
Psychedelics and Suicide-Related Outcomes: A Systematic Review.
PreprintPsilocybin
Human brain changes after first psilocybin use
ArticleMDMA
MDMA-Assisted Psychotherapy for Borderline Personality Disorder.
ArticlePsilocybin
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
ArticleAyahuasca